LAMEA Male Infertility Market By Treatment (Assisted Reproductive Technology & Varicocele Surgery and Medication), By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests), By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Male Infertility Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026).
Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community. High levels of clinically relevant symptoms of depression and anxiety, suicidal thoughts, and a heavy conceptualization of grief impact infertile individuals. Mental health and psychosocial problems and resources need to address key factors of depression, such as poverty, sexual abuse, and infertility.
Growing rates of infertility worldwide and the introduction of assisted reproductive technologies (ARTs) are expected to push the demand for male infertility in the coming years. ARTs address a wide variety of infertility therapies that provide remedies for males facing issues such as reduced sperm count, irregular sperm quality, and poor motility. In addition, ARTs deliver a high success rate compared to drugs. The demand for male infertility is expected to see substantial development in the future due to technical developments in the area of assisted reproductive technology.
Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
Elements of adult and gender identity can never be realized in infertile individuals due to the loss of pregnancy, childbirth, and lack of family and generational continuity and inclusiveness within their wider community. High levels of clinically relevant symptoms of depression and anxiety, suicidal thoughts, and a heavy conceptualization of grief impact infertile individuals. Mental health and psychosocial problems and resources need to address key factors of depression, such as poverty, sexual abuse, and infertility.
Growing rates of infertility worldwide and the introduction of assisted reproductive technologies (ARTs) are expected to push the demand for male infertility in the coming years. ARTs address a wide variety of infertility therapies that provide remedies for males facing issues such as reduced sperm count, irregular sperm quality, and poor motility. In addition, ARTs deliver a high success rate compared to drugs. The demand for male infertility is expected to see substantial development in the future due to technical developments in the area of assisted reproductive technology.
Tobacco smoke contains approximately 4,000 compounds, like alkaloids, nitrosamines, and inorganic molecules, and some of these are reactive oxygen or nitrogen species. A positive and significant association has been identified between active smoking and sperm DNA fragmentation and also axonemal damage. Smoking is often associated with a decreased sperm count. Smoking is considered to enhance spermatogenesis by increasing the production of norepinephrine, which increases the conversion of testosterone to estrogen causing decreased testosterone levels.
Based on Treatment, the market is segmented into Assisted Reproductive Technology & Varicocele Surgery and Medication. Based on Test, the market is segmented into DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Microscopic Examination, Sperm Agglutination, Sperm Penetration Assay and Other Tests. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sanofi S.A., Bayer AG, Cadila Healthcare Ltd. (Zydus Cadila), Endo International PLC, Aytu BioScience, Inc., Vitrolife AB, SCSA Diagnostics, Inc., Andrology Solutions Limited, Halotech DNA SL, and Intas Pharmaceutical Ltd.
Scope of the Study
Market Segmentation:
By Treatment
- Assisted Reproductive Technology & Varicocele Surgery and
- Medication
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Computer Assisted Semen Analysis
- Microscopic Examination
- Sperm Agglutination
- Sperm Penetration Assay and
- Other Tests
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Sanofi S.A.
- Bayer AG
- Cadila Healthcare Ltd. (Zydus Cadila)
- Endo International PLC
- Aytu BioScience, Inc.
- Vitrolife AB
- SCSA Diagnostics, Inc.
- Andrology Solutions Limited
- Halotech DNA SL
- Intas Pharmaceutical Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Male Infertility Market, by Treatment
1.4.2 LAMEA Male Infertility Market, by Tests
1.4.3 LAMEA Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA MALE INFERTILITY MARKET BY TREATMENT
3.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 LAMEA Medication Market by Country
CHAPTER 4. LAMEA MALE INFERTILITY MARKET BY TEST
4.1 LAMEA DNA Fragmentation Technique Market by Country
4.2 LAMEA Oxidative Stress Analysis Market by Country
4.3 LAMEA Computer Assisted Semen Analysis Market by Country
4.4 LAMEA Microscopic Examination Market by Country
4.5 LAMEA Sperm Agglutination Market by Country
4.6 LAMEA Sperm Penetration Assay Market by Country
4.7 LAMEA Other Test Market by Country
CHAPTER 5. LAMEA MALE INFERTILITY MARKET BY COUNTRY
5.1 Brazil Male Infertility Market
5.1.1 Brazil Male Infertility Market by Treatment
5.1.2 Brazil Male Infertility Market by Test
5.2 Argentina Male Infertility Market
5.2.1 Argentina Male Infertility Market by Treatment
5.2.2 Argentina Male Infertility Market by Test
5.3 UAE Male Infertility Market
5.3.1 UAE Male Infertility Market by Treatment
5.3.2 UAE Male Infertility Market by Test
5.4 Saudi Arabia Male Infertility Market
5.4.1 Saudi Arabia Male Infertility Market by Treatment
5.4.2 Saudi Arabia Male Infertility Market by Test
5.5 South Africa Male Infertility Market
5.5.1 South Africa Male Infertility Market by Treatment
5.5.1.1.1 South Africa Male Infertility Market by Test
5.6 Nigeria Male Infertility Market
5.6.1 Nigeria Male Infertility Market by Treatment
5.6.2 Nigeria Male Infertility Market by Test
5.7 Rest of LAMEA Male Infertility Market
5.7.1 Rest of LAMEA Male Infertility Market by Treatment
5.7.2 Rest of LAMEA Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Male Infertility Market, by Treatment
1.4.2 LAMEA Male Infertility Market, by Tests
1.4.3 LAMEA Male Infertility Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA MALE INFERTILITY MARKET BY TREATMENT
3.1 LAMEA Assisted Reproductive Technology and Varicocele Surgery Market by Country
3.2 LAMEA Medication Market by Country
CHAPTER 4. LAMEA MALE INFERTILITY MARKET BY TEST
4.1 LAMEA DNA Fragmentation Technique Market by Country
4.2 LAMEA Oxidative Stress Analysis Market by Country
4.3 LAMEA Computer Assisted Semen Analysis Market by Country
4.4 LAMEA Microscopic Examination Market by Country
4.5 LAMEA Sperm Agglutination Market by Country
4.6 LAMEA Sperm Penetration Assay Market by Country
4.7 LAMEA Other Test Market by Country
CHAPTER 5. LAMEA MALE INFERTILITY MARKET BY COUNTRY
5.1 Brazil Male Infertility Market
5.1.1 Brazil Male Infertility Market by Treatment
5.1.2 Brazil Male Infertility Market by Test
5.2 Argentina Male Infertility Market
5.2.1 Argentina Male Infertility Market by Treatment
5.2.2 Argentina Male Infertility Market by Test
5.3 UAE Male Infertility Market
5.3.1 UAE Male Infertility Market by Treatment
5.3.2 UAE Male Infertility Market by Test
5.4 Saudi Arabia Male Infertility Market
5.4.1 Saudi Arabia Male Infertility Market by Treatment
5.4.2 Saudi Arabia Male Infertility Market by Test
5.5 South Africa Male Infertility Market
5.5.1 South Africa Male Infertility Market by Treatment
5.5.1.1.1 South Africa Male Infertility Market by Test
5.6 Nigeria Male Infertility Market
5.6.1 Nigeria Male Infertility Market by Treatment
5.6.2 Nigeria Male Infertility Market by Test
5.7 Rest of LAMEA Male Infertility Market
5.7.1 Rest of LAMEA Male Infertility Market by Treatment
5.7.2 Rest of LAMEA Male Infertility Market by Test
CHAPTER 6. COMPANY PROFILES
6.1 Sanofi S.A.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bayer AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cadila Healthcare Ltd. (Zydus Cadila)
6.3.1 Company Overview
6.3.1 Financial Analysis
6.3.2 Regional Analysis
6.3.3 Research & Development Expense
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expense
6.5 Aytu BioScience, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.5.5.2 Partnerships, Collaborations, and Agreements:
6.6 Vitrolife AB
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 SCSA Diagnostics, Inc.
6.7.1 Company Overview
6.8 Andrology Solutions Limited
6.8.1 Company Overview
6.9 Halotech DNA SL
6.9.1 Company Overview
6.1 Intas Pharmaceutical Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 BRAZIL MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 BRAZIL MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 BRAZIL MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 BRAZIL MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 ARGENTINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 ARGENTINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 UAE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 UAE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 UAE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 UAE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 UAE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 UAE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 SAUDI ARABIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SAUDI ARABIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SOUTH AFRICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SOUTH AFRICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 NIGERIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 NIGERIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 NIGERIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 NIGERIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
TABLE 1 LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 4 LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 5 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA ASSISTED REPRODUCTIVE TECHNOLOGY AND VARICOCELE SURGERY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA MEDICATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA MEDICATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 10 LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 11 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA DNA FRAGMENTATION TECHNIQUE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA OXIDATIVE STRESS ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA COMPUTER ASSISTED SEMEN ANALYSIS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA MICROSCOPIC EXAMINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA SPERM AGGLUTINATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA SPERM PENETRATION ASSAY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA OTHER TEST MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA OTHER TEST MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA MALE INFERTILITY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 BRAZIL MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 28 BRAZIL MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 31 BRAZIL MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 32 BRAZIL MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 33 ARGENTINA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 34 ARGENTINA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 37 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 38 ARGENTINA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 39 UAE MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 40 UAE MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 41 UAE MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 42 UAE MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 43 UAE MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 44 UAE MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 45 SAUDI ARABIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 46 SAUDI ARABIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 48 SAUDI ARABIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 49 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 50 SAUDI ARABIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 51 SOUTH AFRICA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 52 SOUTH AFRICA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 53 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 54 SOUTH AFRICA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 55 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 56 SOUTH AFRICA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 57 NIGERIA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 58 NIGERIA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 59 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 60 NIGERIA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 61 NIGERIA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 62 NIGERIA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 63 REST OF LAMEA MALE INFERTILITY MARKET, 2016 - 2019, USD MILLION
TABLE 64 REST OF LAMEA MALE INFERTILITY MARKET, 2020 - 2026, USD MILLION
TABLE 65 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2016 - 2019, USD MILLION
TABLE 66 REST OF LAMEA MALE INFERTILITY MARKET BY TREATMENT, 2020 - 2026, USD MILLION
TABLE 67 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2016 - 2019, USD MILLION
TABLE 68 REST OF LAMEA MALE INFERTILITY MARKET BY TEST, 2020 - 2026, USD MILLION
TABLE 69 KEY INFORMATION – SANOFI S.A.
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION – CADILA HEALTHCARE LTD.
TABLE 72 KEY INFORMATION – ENDO INTERNATIONAL PLC
TABLE 73 KEY INFORMATION – AYTU BIOSCIENCE, INC.
TABLE 74 KEY INFORMATION – VITROLIFE AB
TABLE 75 KEY INFORMATION – SCSA DIAGNOSTICS, INC.
TABLE 76 KEY INFORMATION – ANDROLOGY SOLUTIONS LIMITED
TABLE 77 KEY INFORMATION – HALOTECH DNA SL
TABLE 78 KEY INFORMATION – INTAS PHARMACEUTICAL LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
